We concur with Dr Benitz' thoughtful analysis of earlier studies and limited epidemiologic data. The increased incidence of GBS in twin gestation overall may only reflect the well-established increased rate of premature delivery in multiple gestations. With respect to management of the second twin after diagnosis of invasive GBS disease in an index case, careful clinical evaluation can be augmented by laboratory studies including a complete differential blood count and blood culture. We advocate empiric therapy (e.g., 50 mg/kg ceftriaxone every 24 hours) only until occult bacteremia is ruled out by negative culture at 48 hours.
